Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers
- 30 November 1987
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 15 (6) , 569-582
- https://doi.org/10.1007/bf01068413
Abstract
In an attempt to evaluate the propranolol (P) concentration-effect relationship, percentage reduction in exercise heart rate was modeled as a function of unbound and total P concentrations using the linear, E max ,and sigmoid E max models. Nine volunteers underwent repeated treadmill exercise tests over 48 hr during a control period, after receiving 160 mg of P orally and again after receiving 160 mg once daily for 7 days. Beta blockade was assessed as the percentage reduction in exercise heart rate compared to control. Total serum P concentrations were determined by HPLC and unbound fractions by equilibrium dialysis. Using nonlinear least-squares regression, the E max model was best in describing the concentration-effect relationship in each subject. Mean parameters for combined single dose and steady state were E max 33.6±4.5% and EC50 18.2±15.6ng/ml for total P and E max 33.5±4.3% and EC50 1.66±1.56 for unbound P. Model fits were not significantly better for unbound versus total P and EC50 values showed similar intersubject variability. The observed unbound EC50 values are consistent with reported receptor dissociation constants. Therefore the large intersubject variability in EC50 could not be accounted for by variability in P protein binding.This publication has 21 references indexed in Scilit:
- Nonlinear Pharmacokinetics of Unbound Propranolol after Oral AdministrationJournal of Pharmaceutical Sciences, 1987
- Pharmacokinetic and pharmacodynamic studies with a new controlled‐ release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.British Journal of Clinical Pharmacology, 1984
- Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.Circulation Research, 1983
- Errors in Estimating the Unbound Fraction of Drugs Due to the Volume Shift in Equilibrium DialysisJournal of Pharmaceutical Sciences, 1983
- An Automated HPLC Method for the Assay of Propranolol and Its Basic Metabolites in Plasma and UrineJournal of Chromatographic Science, 1982
- Kinetics of pharmacologic responsePharmacology & Therapeutics, 1982
- Importance of Radiochemical Purity of Radiolabeled Drugs Used for Determining Plasma Protein Binding of DrugsJournal of Pharmaceutical Sciences, 1981
- Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.Published by Wiley ,1978
- Plasma Propranolol Levels in the Quantitative Assessment of -adrenergic Blockade in ManBMJ, 1970
- Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and manJournal of Theoretical Biology, 1968